Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Preventicus GmbH | INDUSTRY |
| Versicherungskammer Bayern | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Atrial fibrillation (AF) is the most common arrhythmia in western countries and causes of up to one quarter of ischemic strokes. The randomized eHealth-based Bavarian Alternative Detection of Atrial Fibrillation study (eBRAVE-AF) tests the efficacy of an e-health based strategy for the detection of AF. The e-health-based strategy consists of a smartphone-based photophlethysmographic (PPG) screening and an ECG-based validation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention group | Experimental | e-health-based strategy |
|
| control group | No Intervention | symptom based AF-screening |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| e-Health based strategy: PPG-based screening using a smartphone and ECG patch | Diagnostic Test | PPG-analysis via Smartphone-App (Preventicus Heart Beats) and ECG patch |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with newly diagnosed atrial fibrillation within six months with prescription of oral anticoagulation | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with newly diagnosed atrial fibrillation | 6 months | |
| Number of participants with newly prescribed oral anticoagulation | 6 months | |
| Number of participants with stroke |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with TIMI major bleeding | 6 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Axel Bauer, MD | LMU Klinikum | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Klinikum der Universität München | München | 81337 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36031651 | Derived | Rizas KD, Freyer L, Sappler N, von Stulpnagel L, Spielbichler P, Krasniqi A, Schreinlechner M, Wenner FN, Theurl F, Behroz A, Eiffener E, Klemm MP, Schneidewind A, Zens M, Dolejsi T, Mansmann U, Massberg S, Bauer A. Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial. Nat Med. 2022 Sep;28(9):1823-1830. doi: 10.1038/s41591-022-01979-w. Epub 2022 Aug 28. | |
| 34252387 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Number of participants with thromboembolic events | 6 months |
| Derived |
| Freyer L, von Stulpnagel L, Spielbichler P, Sappler N, Wenner F, Schreinlechner M, Krasniqi A, Behroz A, Eiffener E, Zens M, Dolejsi T, Massberg S, Rizas KD, Bauer A. Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trial. Am Heart J. 2021 Nov;241:26-34. doi: 10.1016/j.ahj.2021.06.008. Epub 2021 Jul 9. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |